Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 382,004 | 406,264 | 436,585 | 471,429 | 272,122 |
Marketable Securities | 150,855 | 103,239 | 83,271 | 38,075 | 19,052 |
Receivables | 109,599 | 47,205 | 46,394 | 35,374 | 33,197 |
Inventories | 402 | 269 | 347 | 406 | 359 |
Income taxes - deferred | 775 | 900 | 892 | 895 | N/A |
TOTAL | $662,614 | $577,145 | $581,170 | $555,799 | $333,743 |
Non-Current Assets | |||||
PPE Net | 75,258 | 55,607 | 38,654 | 26,848 | 6,201 |
Investments And Advances | 14,125 | 14,250 | 14,375 | 14,500 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 2,508 |
Other Non-Current Assets | 33,268 | 32,105 | 32,627 | 32,421 | 14,948 |
TOTAL | $122,651 | $101,962 | $85,656 | $73,769 | $23,657 |
Total Assets | $785,265 | $679,107 | $666,826 | $629,568 | $357,400 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 31,061 | 29,101 | 22,412 | 21,011 | 24,299 |
Accrued Expenses | 80,717 | 70,561 | 71,645 | 74,141 | 59,696 |
TOTAL | $124,660 | $112,547 | $106,944 | $108,042 | $109,498 |
Non-Current Liabilities | |||||
Deferred Revenues | 12,882 | 12,885 | 12,887 | 12,890 | 25,503 |
aiOther Non-Current Liabilities | 733,695 | 717,718 | 699,258 | 688,370 | 190,528 |
TOTAL | $750,196 | $737,558 | $722,304 | $714,634 | $219,111 |
Total Liabilities | $874,856 | $850,105 | $829,248 | $822,676 | $328,609 |
Shareholders' Equity | |||||
Shares Outstanding, K | 168,942 | 168,412 | 167,628 | 165,537 | 161,120 |
Common Shares | 169 | 168 | 167 | 163 | 161 |
Retained earnings | -1,748,575 | -1,807,867 | -1,770,994 | -1,737,037 | -1,694,166 |
Other shareholders' equity | 1,914 | 2,080 | 2,040 | 1,993 | 2,008 |
TOTAL | $-89,591 | $-170,998 | $-162,422 | $-193,108 | $28,791 |
Total Liabilities And Equity | $785,265 | $679,107 | $666,826 | $629,568 | $357,400 |